-+ 0.00%
-+ 0.00%
-+ 0.00%

*Curis Announces Eleven Active Clinical Sites In TakeAim CLL Study, Reaffirms Patient Dosing Guidance, And Reports Stockholder Approval Of Reverse Stock Split >CRIS

Dow Jones·06/26/2026 13:43:00

Please log in to view news